Hepatitis B: diagnosis and treatment.

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• An estimated 1 million individuals in the US are chronically infected with Hepatitis B Virus (HBV).
• National HBV vaccination programs have led to a decline in HBV prevalence.
• HBV is transmitted through blood and bodily secretions, with acute symptoms including fatigue, jaundice, and abdominal pain.

Purpose of the Study:

• To outline the diagnostic methods for Hepatitis B Virus infection.
• To describe the goals and treatment options for chronic Hepatitis B Virus infection.
• To emphasize the importance of monitoring and surveillance for chronic HBV patients.

Main Methods:

• Diagnosis requires serological testing for Hepatitis B surface antigen, Hepatitis B surface antibody, and Hepatitis B core antibody.
• Treatment strategies involve suppressing viral replication using pegylated interferon alfa-2a or oral nucleotide reverse transcriptase inhibitors.
• Monitoring includes liver enzyme tests, HBV DNA levels, consideration for liver biopsy, and hepatocellular carcinoma surveillance.

Main Results:

• Fewer than 5% of acutely infected adults develop chronic HBV infection.
• Treatment aims to reduce liver inflammation and prevent complications.
• Regular monitoring is crucial for managing chronic HBV and preventing long-term sequelae.

Conclusions:

• Hepatitis B Virus infection diagnosis relies on specific antibody and antigen detection.
• Effective management of chronic HBV involves antiviral therapies and vigilant monitoring.
• Public health initiatives, like vaccination, are critical in controlling HBV prevalence.